ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,275.38
0.54%
Dow Jones
38,686.32
1.51%
Gold vs US Dollar
2,327.355
0.00%
Brent Oil
81.295
0.00%
Bitcoin
67,864.96
0.21%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Veracyte Inc (VCYT)

  7. Veracyte Inc (VCYT) News

Veracyte (VCYT)

Veracyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VCYT
DateTimeSourceHeadlineSymbolCompany
30/05/202421:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
28/05/202421:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:VCYTVeracyte Inc
22/05/202421:05Business WireVeracyte Announces Multiple Afirma GRID Presentations at ENDO 2024, Previewing the Future of Molecular Testing in Thyroid Nodules and CancerNASDAQ:VCYTVeracyte Inc
15/05/202422:04Business WireVeracyte to Participate in Upcoming Investor ConferencesNASDAQ:VCYTVeracyte Inc
08/05/202422:03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VCYTVeracyte Inc
07/05/202421:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
07/05/202421:05Business WireVeracyte Announces First Quarter 2024 Financial ResultsNASDAQ:VCYTVeracyte Inc
06/05/202421:05Business Wire14 Studies Presented at AUA 2024 Show Decipher Tests’ Ability to Help Personalize Care for Prostate and Bladder Cancer Patients and Advance Disease UnderstandingNASDAQ:VCYTVeracyte Inc
22/04/202422:00Business WireVeracyte to Release First Quarter 2024 Financial Results on May 7, 2024NASDAQ:VCYTVeracyte Inc
22/04/202413:30Business WireNew Study Shows Veracyte’s Decipher Prostate Test is Prognostic for Prostate Cancer Progression Among Patients Undergoing Active SurveillanceNASDAQ:VCYTVeracyte Inc
16/04/202413:30Business WireVeracyte Announces that Nine Studies Reinforcing the Value of Decipher Prostate and Decipher Bladder Testing Will Be Presented at AUA 2024NASDAQ:VCYTVeracyte Inc
08/03/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
08/03/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
08/03/202421:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
08/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
08/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
08/03/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
05/03/202422:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
05/03/202422:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
05/03/202422:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
05/03/202422:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
05/03/202422:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VCYTVeracyte Inc
29/02/202422:27Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
29/02/202422:22Edgar (US Regulatory)Form 424B7 - Prospectus [Rule 424(b)(7)]NASDAQ:VCYTVeracyte Inc
29/02/202422:20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:VCYTVeracyte Inc
29/02/202421:40Edgar (US Regulatory)Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuersNASDAQ:VCYTVeracyte Inc
29/02/202413:06Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:VCYTVeracyte Inc
27/02/202422:55Business WireVeracyte’s Decipher Prostate Test Receives Highest Evidence-Level Rating Among Molecular Tests in Updated Prostate Cancer NCCN GuidelinesNASDAQ:VCYTVeracyte Inc
22/02/202421:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VCYTVeracyte Inc
22/02/202421:05Business WireVeracyte Announces Fourth Quarter and Full-Year 2023 Financial ResultsNASDAQ:VCYTVeracyte Inc
 Showing the most relevant articles for your search:NASDAQ:VCYT

Your Recent History

LSE
ZED
Zenova
LSE
KEFI
Kefi Gold And Copper
LSE
CHLL
Chill Brands
LSE
GKP
Gulf Keystone Petroleum
LSE
KRS
Keras Resources
LSE
POS
Plexus
LSE
VOD
Vodafone
LSE
GOLD
LSE
AVCT
Avacta
LSE
RKH
Rockhopper Exploration
LSE
GDR
Genedrive
LSE
VAST
Vast Resources
LSE
TERN
Tern
LSE
ALBA
Alba Mineral Resources
LSE
AGL
Angle
LSE
THG
Thg
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved